FOLH1 and posterior cortical atrophy: In the prospective multicenter randomized proPSMA trial [7] on 302 high-risk PCa patients, PSMA-PET/CT showed a 27% greater accuracy than conventional imaging (92% vs. 65%), with superior performance in the evaluation of both pelvic nodal and distant metastases.